Development of 3T Magnetic Resonance Research Methods for NIA Studies
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
- Magnetic resonance imaging (MRI) studies provide important information on the structure and function of various body systems, including the brain, muscles, joints, heart, and blood vessels. Scientific applications of MRI scans often use techniques that need to be modified or refined before they are used in clinical studies. To develop and modify these techniques for the new Philips 3T Achieva whole-body MRI scanner, researchers are interested in conducting trial MRI scans on healthy individuals and individuals with conditions that require imaging studies.
Objectives:
- To conduct preliminary trials of the 3T MRI facility to develop and refine MRI scanning procedures.
Eligibility:
- Individuals at least 18 years of age who are able to have magnetic resonance imaging.
Design:
- Participants will be screened with a full medical history and physical examination, as well as blood and urine tests.
- Participants will have an MRI scan using the 3T scanner. Some scans may require the use of a contrast agent or radiotracer, which is a small amount of radioactive substance that will be injected before the start of the scan. Some participants may be asked to perform tasks of thinking and movement while in the scanner, in order to test the procedures required for a functional MRI scan.
- No treatment will be provided as part of this protocol.
| Condition |
|---|
|
Aging |
| Study Type: | Observational |
| Official Title: | Development of 3T Magnetic Resonance Research Methods for NIA Studies |
| Estimated Enrollment: | 300 |
| Study Start Date: | August 2008 |
Magnetic resonance imaging (MRI) studies yield important information on the structure and function of various body systems including the brain, muscles, joints, heart, blood vessels and other body areas. Unlike clinical MRI imaging, scientific applications often utilize techniques that either requires de-novo development or modification of existing research or commercially available protocols before implementation in clinical studies. The proposed protocol is intended to allow MRI scanning on human subjects for the development and refinement of MRI scanning procedures before implementation in larger scale clinical National Institute on Aging (NIA) research studies. We will evaluate a variety of MRI pulse sequences on normal volunteers and individuals with a variety of medical conditions to determine optimal protocols for use in normal volunteers and patient populations.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
- INCLUSION CRITERIA:
Age 18 or older.
Control subjects or persons identified by an investigator to have a condition of interest for exploratory studies related to the patient's illness or other feature that is relevant to other or future NIA studies
Capable of providing informed consent
EXCLUSION CRITERIA:
Any condition or non-removable device contraindicated for MRI, as assessed by the attached safety questionnaire.
Weight greater than the specified limit of the scanner bed
Pregnancy
GFR < 60 ml/min/1.73m(2), if receiving IV contrast
Contacts and Locations| Contact: Dimitrios I Kapogiannis, M.D. | (301) 451-9286 | kapogiannisd@mail.nih.gov |
| United States, Maryland | |
| National Institute of Aging, Clinical Research Unit | Recruiting |
| Baltimore, Maryland, United States, 21224 | |
| Principal Investigator: | Dimitrios I Kapogiannis, M.D. | National Institute on Aging (NIA) |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT01324206 History of Changes |
| Other Study ID Numbers: | 999908238, 08-AG-N238 |
| Study First Received: | March 25, 2011 |
| Last Updated: | April 26, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Whole-Body Development Exposure Magnetic Resonance |
ClinicalTrials.gov processed this record on May 19, 2013